38111 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 20
00:53 UTC
|
AEE
Ameren
|
◎ Target | Stephen Byrd ★☆☆☆☆ #3099 | Equal Weight | $114.00→ $108.00-5.3% |
|
Sep 20
00:53 UTC
|
ADC
Agree Realty
|
◎ Target | Simon Yarmak ★★★☆☆ #1317 | Buy | $84.00→ $81.50-3.0% |
|
Sep 20
00:53 UTC
|
ACN
Accenture
|
◎ Target | Nate Svensson ★★☆☆☆ #2433 | Hold | $136.00→ $175.00+28.7% |
|
Sep 20
00:53 UTC
|
ABNB
Airbnb
|
◎ Target | Matthew Condon ★★☆☆☆ #2515 | Market Outperform | $190.00→ $200.00+5.3% |
|
Sep 20
00:53 UTC
|
ABEO
Abeona Therapeutics
|
◎ Target | Kristen Kluska ★☆☆☆☆ #3070 | Overweight | $28.00→ $30.00+7.1% |
|
Sep 20
00:53 UTC
|
AAL
American Airlines Group
|
◎ Target | James Goodall ★★★☆☆ #1198 | Neutral | $12.50→ $13.50+8.0% |
|
Sep 20
00:53 UTC
|
AA
Alcoa
|
◎ Target | Timna Tanners ★★★☆☆ #2020 | Overweight | $71.00→ $60.00-15.5% |
|
Sep 19
00:50 UTC
|
XENE
Xenon Pharmaceuticals
|
◎ Target | Benjamin Burnett ★★★☆☆ #1791 | Overweight | $69.00→ $64.00-7.2% |
|
Sep 19
00:50 UTC
|
XENE
Xenon Pharmaceuticals
|
◎ Target | Brian Skorney ★★☆☆☆ #2420 | Outperform | $97.00→ $90.00-7.2% |
|
Sep 19
00:50 UTC
|
XENE
Xenon Pharmaceuticals
|
◎ Target | Serge Belanger ★★★☆☆ #1966 | Buy | $78.00→ $60.00-23.1% |
|
Sep 19
00:50 UTC
|
XENE
Xenon Pharmaceuticals
|
◎ Target | Laura Chico ★★☆☆☆ #2706 | Outperform | $71.00→ $55.00-22.5% |
|
Sep 19
00:50 UTC
|
XENE
Xenon Pharmaceuticals
|
◎ Target | Brian Abrahams ★★☆☆☆ #2286 | Outperform | $81.00→ $70.00-13.6% |
|
Sep 19
00:50 UTC
|
XEL
Xcel Energy
|
◎ Target | David Arcaro ★★★☆☆ #1881 | Equal Weight | $89.00→ $83.00-6.7% |
|
Sep 19
00:50 UTC
|
UHS
Universal Health Services
|
◎ Target | Whit Mayo ★★★☆☆ #1158 | Outperform | $198.00→ $205.00+3.5% |
|
Sep 19
00:50 UTC
|
UAL
United Airlines
|
◎ Target | James Goodall ★★★☆☆ #1198 | Buy | $165.00→ $150.00-9.1% |
|
Sep 19
00:50 UTC
|
TLN
Talen Energy
|
◎ Target | David Arcaro ★★★☆☆ #1881 | Overweight | $503.00→ $514.00+2.2% |
|
Sep 19
00:50 UTC
|
THG
The Hanover Insurance Group
|
◎ Target | Meyer Shields ★★★★★ #187 | Market Perform | $222.00→ $232.00+4.5% |
|
Sep 19
00:50 UTC
|
SYK
Stryker
|
◎ Target | Kyle Rose not yet tracked | Buy | $400.00→ $385.00-3.8% |
|
Sep 19
00:50 UTC
|
STNG
Scorpio Tankers
|
◎ Target | Gregory Lewis ★☆☆☆☆ #2963 | Buy | $100.00→ $110.00+10.0% |
|
Sep 19
00:50 UTC
|
STLD
Steel Dynamics
|
◎ Target | Timna Tanners ★★★☆☆ #2020 | Overweight | $255.00→ $257.00+0.8% |
|
Sep 19
00:50 UTC
|
STLD
Steel Dynamics
|
◎ Target | Bennett Moore ★★★☆☆ #1848 | Neutral | $273.00→ $272.00-0.4% |
|
Sep 19
00:50 UTC
|
SRE
Sempra Energy
|
◎ Target | David Arcaro ★★★☆☆ #1881 | Overweight | $104.00→ $100.00-3.8% |
|
Sep 19
00:50 UTC
|
SR
Spire
|
◎ Target | Stephen Byrd ★☆☆☆☆ #3099 | Overweight | $91.00→ $88.00-3.3% |
|
Sep 19
00:50 UTC
|
SQM
Sociedad Quimica y Minera
|
◎ Target | Lucas Ferreira ★★★☆☆ #1277 | Neutral | $94.00→ $88.00-6.4% |
|
Sep 19
00:50 UTC
|
SO
Southern
|
◎ Target | Stephen Byrd ★☆☆☆☆ #3099 | Underweight | $89.00→ $85.00-4.5% |
|
Sep 19
00:50 UTC
|
SAIL
SailPoint
|
◎ Target | Tal Liani ★★★★★ #317 | Neutral | $19.00→ $22.00+15.8% |
|
Sep 19
00:50 UTC
|
RGLD
Royal Gold
|
◎ Target | firm only | Buy | $289.00→ $315.00+9.0% |
|
Sep 19
00:50 UTC
|
RDDT
Reddit
|
◎ Target | Wyatt Swanson ★★★☆☆ #1003 | Buy | $200.00→ $185.00-7.5% |
|
Sep 19
00:50 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2797 | Buy | $31.00→ $32.00+3.2% |
|
Sep 19
00:50 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Maxwell Skor ★★★☆☆ #2245 | Equal Weight | $18.00→ $20.00+11.1% |
|
Sep 19
00:50 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Whitney Ijem ★★☆☆☆ #2820 | Buy | $37.00→ $39.00+5.4% |
|
Sep 19
00:50 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Kristen Kluska ★☆☆☆☆ #3070 | Overweight | $33.00→ $39.00+18.2% |
|
Sep 19
00:50 UTC
|
QSR
Restaurant Brands International
|
◎ Target | Gregory Francfort ★★☆☆☆ #2534 | Buy | $85.00→ $86.00+1.2% |
|
Sep 19
00:50 UTC
|
PUBM
PubMatic
|
◎ Target | Naved Khan ★★★★★ #151 | Buy | $17.00→ $21.00+23.5% |
|
Sep 19
00:50 UTC
|
PPL
PPL
|
◎ Target | David Arcaro ★★★☆☆ #1881 | Overweight | $42.00→ $39.00-7.1% |
|
Sep 19
00:50 UTC
|
PNW
Pinnacle West Capital
|
◎ Target | David Arcaro ★★★☆☆ #1881 | Equal Weight | $94.00→ $89.00-5.3% |
|
Sep 19
00:50 UTC
|
PII
Polaris
|
◎ Target | Robin Farley not yet tracked | Neutral | $67.00→ $61.00-9.0% |
|
Sep 19
00:50 UTC
|
PEG
Public Service Enterprise Group
|
◎ Target | David Arcaro ★★★☆☆ #1881 | Overweight | $91.00→ $88.00-3.3% |
|
Sep 19
00:50 UTC
|
PCG
Pacific Gas & Electric
|
◎ Target | David Arcaro ★★★☆☆ #1881 | Equal Weight | $22.00→ $20.00-9.1% |
|
Sep 19
00:50 UTC
|
OSCR
Oscar Health
|
◎ Target | John Ransom ★★★★★ #223 | Outperform | $34.00→ $42.00+23.5% |
|
Sep 19
00:50 UTC
|
ON
onsemi
|
◎ Target | William Stein ★★★☆☆ #2073 | Hold | $91.00→ $75.00-17.6% |
|
Sep 19
00:50 UTC
|
OKTA
Okta
|
◎ Target | Tal Liani ★★★★★ #317 | Neutral | $170.00→ $200.00+17.6% |
|
Sep 19
00:50 UTC
|
OGS
ONE Gas
|
◎ Target | Stephen Byrd ★☆☆☆☆ #3099 | Equal Weight | $82.00→ $79.00-3.7% |
|
Sep 19
00:50 UTC
|
OGE
OGE Energy
|
◎ Target | David Arcaro ★★★☆☆ #1881 | Equal Weight | $49.00→ $46.00-6.1% |
|
Sep 19
00:50 UTC
|
OCS
Oculis
|
◎ Target | Yi Chen ★★☆☆☆ #2512 | Buy | $26.00→ $39.00+50.0% |
|
Sep 19
00:50 UTC
|
NVST
Envista
|
◎ Target | Kevin Caliendo ★★★★☆ #652 | Neutral | $30.00→ $27.00-10.0% |
|
Sep 19
00:50 UTC
|
NUE
Nucor
|
◎ Target | Timna Tanners ★★★☆☆ #2020 | Overweight | $285.00→ $280.00-1.8% |
|
Sep 19
00:50 UTC
|
NRG
NRG Energy
|
◎ Target | Stephen Byrd ★☆☆☆☆ #3099 | Equal Weight | $162.00→ $159.00-1.9% |
|
Sep 19
00:50 UTC
|
NEE
NextEra Energy
|
◎ Target | David Arcaro ★★★☆☆ #1881 | Overweight | $114.00→ $111.00-2.6% |
|
Sep 19
00:50 UTC
|
MTN
Vail Resorts
|
◎ Target | Chris Woronka ★★★★☆ #578 | Hold | $134.00→ $138.00+3.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.